Variant report

Variant	esv3405665
Chromosome Location	chr2:191207532-191210080
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:430)
CpG islands
(count:611)
Chromatin interactive
region (count:3)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:430 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:191208916-191209307	HepG2	liver:	n/a	n/a
2	BACH1	chr2:191208208-191208685	H1-hESC	embryonic stem cell:	n/a	n/a
3	BCLAF1	chr2:191208263-191208755	GM12878	blood:	n/a	chr2:191208546-191208559 chr2:191208425-191208434 chr2:191208554-191208567
4	BHLHE40	chr2:191208274-191209297	HepG2	liver:	n/a	chr2:191208546-191208562 chr2:191208917-191208933
5	BHLHE40	chr2:191208327-191208693	A549	lung:	n/a	chr2:191208546-191208562
6	BHLHE40	chr2:191208196-191209247	GM12878	blood:	n/a	chr2:191208546-191208562 chr2:191208917-191208933
7	BRCA1	chr2:191208345-191208681	Hela-S3	cervix:	n/a	n/a
8	CEBPB	chr2:191208912-191209030	H1-hESC	embryonic stem cell:	n/a	n/a
9	CEBPB	chr2:191208597-191208737	HepG2	liver:	n/a	n/a
10	CEBPB	chr2:191208532-191208835	IMR90	lung:	n/a	n/a
11	CEBPB	chr2:191208535-191209107	HepG2	liver:	n/a	n/a
12	CEBPB	chr2:191208532-191208864	A549	lung:	n/a	n/a
13	CEBPB	chr2:191208481-191209229	Hela-S3	cervix:	n/a	n/a
14	CEBPD	chr2:191208490-191209127	HepG2	liver:	n/a	n/a
15	CEBPZ	chr2:191209541-191209556	HepG2	liver:	n/a	n/a
16	CHD1	chr2:191208631-191209121	GM12878	blood:	n/a	n/a
17	CHD2	chr2:191208909-191209136	HepG2	liver:	n/a	n/a
18	CHD2	chr2:191208400-191209221	H1-hESC	embryonic stem cell:	n/a	n/a
19	CHD2	chr2:191208285-191208686	HepG2	liver:	n/a	n/a
20	CHD2	chr2:191208221-191209140	Hela-S3	cervix:	n/a	n/a
21	CHD2	chr2:191208478-191208757	GM12878	blood:	n/a	n/a
22	CREB1	chr2:191207924-191208678	A549	lung:	n/a	n/a
23	CREB1	chr2:191208104-191208915	H1-hESC	embryonic stem cell:	n/a	n/a
24	CREB1	chr2:191208044-191208789	GM12878	blood:	n/a	n/a
25	CTBP2	chr2:191208139-191209280	H1-hESC	embryonic stem cell:	n/a	n/a
26	CTCF	chr2:191208907-191208913	Gliobla	brain:	n/a	n/a
27	CTCF	chr2:191208960-191209110	NHEK	skin:	n/a	n/a
28	CTCF	chr2:191209020-191209170	HepG2	liver:	n/a	chr2:191209102-191209118
29	CTCF	chr2:191209040-191209190	AG09319	gingival:	n/a	chr2:191209102-191209118
30	CTCF	chr2:191208920-191209070	HCM	heart:	n/a	n/a
31	CTCF	chr2:191208960-191209110	HUVEC	blood vessel:	n/a	n/a
32	CTCF	chr2:191209120-191209270	GM12870	blood:	n/a	n/a
33	CTCF	chr2:191209000-191209150	HPF	lung:	n/a	chr2:191209102-191209118
34	CTCF	chr2:191209040-191209190	HPAF	blood vessel:	n/a	chr2:191209102-191209118
35	CTCF	chr2:191209040-191209190	HRPEpiC	eye:	n/a	chr2:191209102-191209118
36	CTCF	chr2:191208866-191209324	GM12878	blood:	n/a	chr2:191209102-191209118
37	CTCF	chr2:191209060-191209210	GM12865	blood:	n/a	chr2:191209102-191209118
38	CTCF	chr2:191208884-191209244	MCF-7	breast:	n/a	chr2:191209102-191209118
39	CTCF	chr2:191208810-191209250	GM19238	blood:	n/a	chr2:191209102-191209118
40	CTCF	chr2:191208999-191209223	HepG2	liver:	n/a	chr2:191209102-191209118
41	CTCF	chr2:191209020-191209170	GM12869	blood:	n/a	chr2:191209102-191209118
42	CTCF	chr2:191208938-191209221	A549	lung:	n/a	chr2:191209102-191209118
43	CTCF	chr2:191209060-191209210	AoAF	blood vessel:	n/a	chr2:191209102-191209118
44	CTCF	chr2:191208556-191208607	GM19239	blood:	n/a	n/a
45	CTCF	chr2:191209036-191209154	SK-N-SH_RA	brain:	n/a	chr2:191209102-191209118
46	CTCF	chr2:191208783-191209245	GM12892	blood:	n/a	chr2:191209102-191209118
47	CTCF	chr2:191208980-191209130	WERI-Rb-1	eye:	n/a	chr2:191209102-191209118
48	CTCF	chr2:191209018-191209162	LNCaP	prostate:	n/a	chr2:191209102-191209118
49	CTCF	chr2:191208880-191209030	HAc	cerebellar:	n/a	n/a
50	CTCF	chr2:191209040-191209190	HEEpiC	esophagus:	n/a	chr2:191209102-191209118

(count:611 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:191208171-191208221	HEEpiC	esophagus:	n/a
2	chr2:191208171-191208221	HEEpiC	esophagus:	n/a
3	chr2:191207820-191207870	Hepatocyte	liver:	n/a
4	chr2:191208116-191208166	HMEC	breast:	n/a
5	chr2:191208232-191208282	HL-60	blood:	n/a
6	chr2:191208232-191208282	GM12891	blood:	n/a
7	chr2:191208232-191208282	PrEC	prostate:	n/a
8	chr2:191207820-191207870	RPTEC	kidney:	n/a
9	chr2:191208999-191209049	GM12892	blood:	n/a
10	chr2:191208002-191208052	NH-A	brain:	n/a
11	chr2:191208232-191208282	HCPEpiC	choroid plexus:	n/a
12	chr2:191209057-191209107	LNCaP	prostate:	n/a
13	chr2:191209057-191209107	PFSK-1	brain:	n/a
14	chr2:191208694-191208744	HCF	heart:	n/a
15	chr2:191208999-191209049	SK-N-MC	brain:	n/a
16	chr2:191207609-191207659	PrEC	prostate:	n/a
17	chr2:191207820-191207870	SKMC	muscle:	n/a
18	chr2:191208694-191208744	HEK293	kidney:	embryo
19	chr2:191208694-191208744	NT2-D1	testis:	n/a
20	chr2:191208002-191208052	HAEpiC	amniotic membrane:	n/a
21	chr2:191207609-191207659	HRE	kidney:	n/a
22	chr2:191208232-191208282	NH-A	brain:	n/a
23	chr2:191208171-191208221	HepG2	liver:	n/a
24	chr2:191208232-191208282	A549	lung:	n/a
25	chr2:191208002-191208052	SKMC	muscle:	n/a
26	chr2:191207609-191207659	PANC-1	pancreas:	n/a
27	chr2:191208002-191208052	NB4	blood:	n/a
28	chr2:191209022-191209072	HIPEpiC	eye:	n/a
29	chr2:191208002-191208052	HCPEpiC	choroid plexus:	n/a
30	chr2:191207609-191207659	AG09309	skin:	n/a
31	chr2:191209022-191209072	GM12892	blood:	n/a
32	chr2:191207609-191207659	HRCEpiC	kidney:	n/a
33	chr2:191208171-191208221	Hepatocyte	liver:	n/a
34	chr2:191207820-191207870	HPAEpiC	pulmonary alveolar:	n/a
35	chr2:191208002-191208052	HCT-116	colon:	n/a
36	chr2:191209022-191209072	HCF	heart:	n/a
37	chr2:191208002-191208052	HRCEpiC	kidney:	n/a
38	chr2:191208002-191208052	LNCaP	prostate:	n/a
39	chr2:191209057-191209107	HIPEpiC	eye:	n/a
40	chr2:191208999-191209049	SAEC	small airway:	n/a
41	chr2:191209057-191209107	IMR90	lung:	fetal
42	chr2:191209057-191209107	SKMC	muscle:	n/a
43	chr2:191207609-191207659	CMK	blood:	n/a
44	chr2:191207820-191207870	Jurkat	blood:	n/a
45	chr2:191208002-191208052	BE2_C	brain:	n/a
46	chr2:191209022-191209072	U87	brain:	n/a
47	chr2:191207820-191207870	MCF10A-Er-Src	breast:	n/a
48	chr2:191208999-191209049	Jurkat	blood:	n/a
49	chr2:191208999-191209049	IMR90	lung:	fetal
50	chr2:191208232-191208282	SKMC	muscle:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:191209219..191211373-chr2:191219117..191222067,2	MCF-7	breast:
2	chr2:191207151..191209417-chr2:191272894..191274824,2	MCF-7	breast:
3	chr2:191184511..191186549-chr2:191207772..191209465,2	MCF-7	breast:

No data

Variant related genes	Relation type
HIBCH	TF binding region
INPP1	TF binding region
HIBCH	CpG island
INPP1	CpG island
ENSG00000198130	chromatin interactions
ENSG00000151689	chromatin interactions
ENSG00000151690	chromatin interactions

Extended variants
information (count: 82 )
Associated
traits (count: 47 )

Variant overlapped rSNPs/rCNVs (count:82 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs564436426	chr2:191207533-191207534	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs189361867	chr2:191207536-191207537	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs540269134	chr2:191207573-191207574	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs192227014	chr2:191207581-191207582	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs576046795	chr2:191207598-191207599	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs545448834	chr2:191207738-191207739	Active TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs564666458	chr2:191207739-191207740	Active TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs377527902	chr2:191207772-191207773	Active TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs577015449	chr2:191207783-191207784	Active TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs543931333	chr2:191207797-191207798	Active TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs550284621	chr2:191207801-191207802	Active TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs562223622	chr2:191207846-191207847	Active TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs531045329	chr2:191207853-191207854	Active TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs552486640	chr2:191207890-191207891	Active TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs2067386	chr2:191207974-191207975	Active TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs529630065	chr2:191207982-191207983	Active TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs528786580	chr2:191207998-191207999	Active TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs547233570	chr2:191208002-191208003	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs568483303	chr2:191208023-191208024	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs139875338	chr2:191208045-191208046	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs545241230	chr2:191208061-191208062	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs371305723	chr2:191208062-191208063	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs2067387	chr2:191208182-191208183	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs78260468	chr2:191208189-191208190	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs569356454	chr2:191208195-191208196	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs565221236	chr2:191208252-191208253	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs112615459	chr2:191208257-191208258	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs539656521	chr2:191208292-191208293	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs557665768	chr2:191208296-191208297	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs2028431	chr2:191208341-191208342	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
31	rs1372054	chr2:191208347-191208348	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
32	rs555214959	chr2:191208350-191208351	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs527574010	chr2:191208374-191208375	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs573331539	chr2:191208465-191208466	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs543790015	chr2:191208473-191208474	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs371122648	chr2:191208529-191208530	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs532886041	chr2:191208554-191208555	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs2067388	chr2:191208571-191208572	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs564536459	chr2:191208602-191208603	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs3186917	chr2:191208609-191208610	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs528653740	chr2:191208662-191208663	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs547337616	chr2:191208787-191208788	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs760307	chr2:191208795-191208796	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
44	rs374452586	chr2:191208863-191208864	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs113429924	chr2:191208865-191208866	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
46	rs2067389	chr2:191208895-191208896	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs569421045	chr2:191208919-191208920	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
48	rs570267810	chr2:191208953-191208954	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
49	rs189585578	chr2:191208956-191208957	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs558190319	chr2:191208994-191208995	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:47)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Testicular germ cell tumor	18059402	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Lung cancer	18438408	CNVD
Glioblastoma	21080181	CNVD
Prostate cancer	18632612	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Facial dysmorphism	20548289	CNVD
Mental retardation	20548289	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Hirschsprung''s Disease	21712996	CNVD
Cancer	21183584	CNVD
Ovarian cancer	21720365	CNVD
Immune disease	21076436	CNVD
Immune disease	21042300	CNVD
Colorectal cancer	16912164	CNVD
Breast cancer	21364760	CNVD

Chromatin state (count:507 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:191191600-191208000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
2	chr2:191198400-191207600	Weak transcription	NHLF	lung
3	chr2:191198600-191208000	Weak transcription	Aorta	Aorta
4	chr2:191198800-191208000	Weak transcription	Ovary	ovary
5	chr2:191199600-191207600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
6	chr2:191199600-191208000	Weak transcription	HMEC	breast
7	chr2:191200600-191208000	Weak transcription	Left Ventricle	heart
8	chr2:191204200-191208000	Enhancers	HepG2	liver
9	chr2:191205600-191207600	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
10	chr2:191205600-191207600	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
11	chr2:191205800-191216200	Weak transcription	K562	blood
12	chr2:191206800-191208000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
13	chr2:191206800-191208200	Enhancers	Small Intestine	intestine
14	chr2:191207000-191207800	Enhancers	Primary neutrophils fromperipheralblood	blood
15	chr2:191207200-191207600	Enhancers	Brain Angular Gyrus	brain
16	chr2:191207200-191207600	Enhancers	Brain Hippocampus Middle	brain
17	chr2:191207200-191207800	Enhancers	Hela-S3	cervix
18	chr2:191207200-191208000	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
19	chr2:191207200-191208000	Enhancers	Brain Substantia Nigra	brain
20	chr2:191207200-191208000	Enhancers	Fetal Intestine Small	intestine
21	chr2:191207200-191208000	Enhancers	Fetal Stomach	stomach
22	chr2:191207400-191207600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
23	chr2:191207400-191207600	Enhancers	Breast Myoepithelial Primary Cells	Breast
24	chr2:191207400-191207600	Enhancers	Brain Cingulate Gyrus	brain
25	chr2:191207400-191207600	Enhancers	Brain Inferior Temporal Lobe	brain
26	chr2:191207400-191207600	Enhancers	Duodenum Mucosa	Duodenum
27	chr2:191207400-191207600	Active TSS	Stomach Smooth Muscle	stomach
28	chr2:191207400-191207800	Enhancers	H9 Cell Line	embryonic stem cell
29	chr2:191207400-191207800	Enhancers	Primary hematopoietic stem cells	blood
30	chr2:191207400-191207800	Enhancers	Colon Smooth Muscle	Colon
31	chr2:191207400-191207800	Enhancers	Lung	lung
32	chr2:191207400-191207800	Enhancers	Skeletal Muscle Male	skeletal muscle
33	chr2:191207400-191207800	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
34	chr2:191207400-191207800	Enhancers	A549	lung
35	chr2:191207400-191207800	Enhancers	Monocytes-CD14+_RO01746	blood
36	chr2:191207400-191208000	Active TSS	ES-I3 Cell Line	embryonic stem cell
37	chr2:191207400-191208000	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
38	chr2:191207400-191208000	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
39	chr2:191207400-191208000	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
40	chr2:191207400-191208000	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
41	chr2:191207400-191208000	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
42	chr2:191207400-191208000	Enhancers	Primary monocytes fromperipheralblood	blood
43	chr2:191207400-191208000	Enhancers	Primary T helper cells PMA-I stimulated	--
44	chr2:191207400-191208000	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
45	chr2:191207400-191208000	Enhancers	Liver	Liver
46	chr2:191207400-191208000	Flanking Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
47	chr2:191207400-191208000	Enhancers	Esophagus	oesophagus
48	chr2:191207400-191208000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
49	chr2:191207400-191208000	Enhancers	Fetal Muscle Leg	muscle
50	chr2:191207400-191208000	Enhancers	Placenta	Placenta

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links